Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience

Andrew Schaefer1 Department of Medicine, University of Wisconsin, Madison, WI, USA

Ying Huang2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Adam Kittai2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Joseph E Maakaron3 Department of Medicine, University of Minnesota, Minneapolis, MN, USA

Caner Saygin4 Department of Medicine, University of Chicago, Chicago, IL, USA

Jonathan Brammer2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Sam Penza2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Ayman Saad2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Samantha M Jaglowski2 Department of Internal Medicine, The Ohio State University, Columbus, OH, USA

Basem M William5 OhioHealth Blood and Marrow Transplant Program, Columbus, OH, USACorrespondence[email protected]

References